Home › Funds › Arrowstreet Capital › NRIX
Arrowstreet Capital position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q2 2026)477.14K sh
Reported value held$11.58M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 195.14K | $2.01K | New |
| Q1 2024 | 187.74K | $2.76K | Reduce |
| Q2 2024 | 60.08K | $1.25K | Reduce |
| Q2 2026 | 477.14K | $11.58M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026
- Goldman Sachs Group 813.59K sh · $19.74M · Q2 2026